Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tivic Health Systems, Inc. - Common stock (NQ: TIVC )

3.290 +0.110 (+3.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Tivic Health Systems, Inc. - Common stock

< Previous 1 2 3 4 Next >
Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Systems, Inc. Announces Reverse Stock Split
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma
From Tivic Health Systems, Inc.
Via Business Wire
CEO Letter to Shareholders Issued by Tivic Health
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update
From Tivic Health Systems, Inc.
Via Business Wire
Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Validates European Patents in Great Britain, Germany, and France
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14
From Tivic Health Systems, Inc.
Via Business Wire
First Subject Enrolled in Tivic Health’s Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Accelerates VNS Commercial Strategy Development
From Tivic Health® Systems, Inc.
Via Business Wire
Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Reports Second Quarter 2024 Financial Results
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health to Report Q2 2024 Financial Results and Corporate Update on August 14th Via Conference Call and Webcast
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Announces 2024 Annual Meeting of Stockholders
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Expands Intellectual Property Portfolio
From Tivic Health Systems, Inc.
Via Business Wire
BioMedNewsBreaks – Tivic Health(R) Systems (NASDAQ: TIVC) Names New Board Member
Via Investor Brand Network
Exposures Product Safety
Tivic Health: Christina Valauri Appointed to Board of Directors
From Tivic Health® Systems, Inc.
Via Business Wire
Tivic Health Partners with the Feinstein Institutes to Advance its Patent-pending, Non-Invasive Cervical Vagus Nerve Stimulation; Begins Optimization of ncVNS for use in Clinical Indications
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Reports First Quarter 2024 Financial Results and Subsequent Events
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health to Report Q1 2024 Financial Results and Subsequent Events on May 15th Via Conference Call and Webcast
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Announces Closing of $4.0 Million Public Offering
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Announces Pricing of $4.0 Million Public Offering
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health Announces Successful Completion of Non-Invasive Vagus Nerve Stimulation Study (VNS); Demonstrates Clinically Effective Biological Changes in the Autonomic, Cardiac, and Central Nervous Systems
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Reports Fiscal Year 2023 Financial Results
From Tivic Health Systems, Inc.
Via Business Wire
Tivic Health to Report 2023 Year-End Financial Results on March 25th Via Conference Call and Webcast
From Tivic Health Systems, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.